RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

According to wastewater data aggregated by the Centers for Disease Control and Prevention, not only was there less Covid ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Just before he exited the White House, one of President Joe Biden’s last official acts was to grant a preemptive pardon to Dr. Anthony Fauci, who has ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

While levels of one respiratory virus have reduced significantly in NC since January, the risk of contracting a respiratory virus remains very real.

SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse ...

President Donald Trump's effort to unilaterally wind down the United States Agency for International Development (USAID) has ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Five years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.